---
figid: PMC3368374__IJE2012-127362.001
figtitle: In young muscle, abundant serum IGF-I can stimulate protein synthesis by
  activating Akt/mTOR/p70S6K pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC3368374
filename: IJE2012-127362.001.jpg
figlink: /pmc/articles/PMC3368374/figure/fig1/
number: F1
caption: (a) In young muscle, abundant serum IGF-I can stimulate protein synthesis
  by activating Akt/mTOR/p70S6K pathway. Akt blocks the nuclear translocation of FOXO
  to inhibit the expression of Atrogin-1 and MuRF and the consequent protein degradation.
  Abundant serum GH, which is induced by ghrelin, activates JAK2-STAT5 signaling to
  promote muscle-specific gene transcription necessary to hypertrophy. In young muscle,
  testosterone and estrogen bind these intramuscular receptors (androgen receptor
  and estrogen receptor (α and β)), and activate mTOR and Akt, respectively. Lower
  serum amount of myostatin and TNF-α failed to activate signaling candidates (Smad
  2/3, NF-κB, etc.) enhancing protein degradation. (b) In sarcopenic muscle, myostatin
  signals through the activin receptor IIB (ActRIIB), ALK4/5 heterodimer seems to
  activate Smad2/3 and blocking of MyoD transactivation in an autoregulatory feedback
  loop. Abundant activated Smad2/3 inhibit protein synthesis probably due to blocking
  the functional role of Akt. The increased blood TNF-α elevates the protein degradation
  through IKK/NF-κB signaling and enhance an apoptosis. Lower serum amount of IGF-I,
  GH, and anabolic hormones (testosterone and estrogen) failed to activate signaling
  candidates (Akt, mTOR, STAT5, etc.) enhancing protein synthesis. The impaired regulation
  of FOXO by Akt results in abundant expression of Atrogin-1 and MuRF and the consequent
  protein degradation in sarcopenic muscle.
papertitle: Sarcopenia and Age-Related Endocrine Function.
reftext: Kunihiro Sakuma, et al. Int J Endocrinol. 2012;2012:127362.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8794806
figid_alias: PMC3368374__F1
figtype: Figure
redirect_from: /figures/PMC3368374__F1
ndex: f1ff9c29-df11-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3368374__IJE2012-127362.001.html
  '@type': Dataset
  description: (a) In young muscle, abundant serum IGF-I can stimulate protein synthesis
    by activating Akt/mTOR/p70S6K pathway. Akt blocks the nuclear translocation of
    FOXO to inhibit the expression of Atrogin-1 and MuRF and the consequent protein
    degradation. Abundant serum GH, which is induced by ghrelin, activates JAK2-STAT5
    signaling to promote muscle-specific gene transcription necessary to hypertrophy.
    In young muscle, testosterone and estrogen bind these intramuscular receptors
    (androgen receptor and estrogen receptor (α and β)), and activate mTOR and Akt,
    respectively. Lower serum amount of myostatin and TNF-α failed to activate signaling
    candidates (Smad 2/3, NF-κB, etc.) enhancing protein degradation. (b) In sarcopenic
    muscle, myostatin signals through the activin receptor IIB (ActRIIB), ALK4/5 heterodimer
    seems to activate Smad2/3 and blocking of MyoD transactivation in an autoregulatory
    feedback loop. Abundant activated Smad2/3 inhibit protein synthesis probably due
    to blocking the functional role of Akt. The increased blood TNF-α elevates the
    protein degradation through IKK/NF-κB signaling and enhance an apoptosis. Lower
    serum amount of IGF-I, GH, and anabolic hormones (testosterone and estrogen) failed
    to activate signaling candidates (Akt, mTOR, STAT5, etc.) enhancing protein synthesis.
    The impaired regulation of FOXO by Akt results in abundant expression of Atrogin-1
    and MuRF and the consequent protein degradation in sarcopenic muscle.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Jak2
  - Smad2
  - Smad3
  - Akt1
  - Tsc2
  - Nfkb1
  - Rheb
  - Mtor
  - Fbxo32
  - Trim63
  - Eif4e
  - Igf1
  - Tnf
  - Ggh
  - Tgfbr1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - JAK2
  - SMAD2
  - SMAD3
  - AKT1
  - AKT2
  - AKT3
  - MYOD1
  - TSC2
  - NFKB1
  - RHEB
  - RHEBP1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - MTOR
  - TRIM54
  - EIF4E
  - IGF1
  - TNF
  - GGH
  - ACVR2B
  - ACVR1B
  - TGFBR1
  - IGF1R
  - Myod1
  - Trim54
  - Gh
  - Acvr2b
  - Acvr1b
  - jak2b
  - smad2
  - smad3a
  - myod1
  - tsc2
  - rheb
  - rhebl1
  - mtor
  - fbxo32
  - eif4e1b
  - eif4ea
  - igf1
  - kita
  - ngfra
  - tnfb
  - ggh
  - acvr2ba
  - acvr1ba
  - igf1rb
  - Androgen
  - Estrogen
  - O Estrogen
  - Testosterone
  - Cancer
---
